CDKN2A and head and neck squamous cell carcinoma: Supported by immunohistochemistry, FISH or RT–PCR, four earlier studies reported that the co-occurrence of CCND1 overexpression or gain and the CDKN2A loss of expression, under-expression, or deletion marks a specific group in HNSCC with poor prognosis [40,41,42,43].